ACRS · CIK 0001557746 · FY2025 live · 2025-12-31
Aclaris Therapeutics, Inc.
View as
Model
Classic Z
FY2025
−8.38
Zone
Distress
Prior
—
Market DD
—
1y PD
—
Meridian Rank
15.91
0–100 · Classic Z tape · not a PD
Book standing
11
Year change
—
Market PD
—
O-score
29
−8.38
Z″ −18.21
Score −8.38 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.421.2 × = 0.51X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−6.031.4 × = −8.44X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.483.3 × = −1.57X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
1.800.6 × = 1.08X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.051 × = 0.05
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
Aclaris Therapeutics, Inc. is on classic Z at −8.38 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 19th percentile in Healthcare.
- VRCADistressVerrica Pharmaceuticals Inc.−8.42
- RMTIDistressROCKWELL MEDICAL, INC.−8.44
- GUTSDistressFRACTYL HEALTH, INC.−8.31
- SCLXDistressScilex Holding Co−8.26
- SRZNDistressSurrozen, Inc./DE−8.25
- SLGLDistressSol-Gel Technologies Ltd.−8.51
- AKTXDistressAkari Therapeutics Plc−8.23
- KPRXDistressKIORA PHARMACEUTICALS INC−8.56
KPI widgets
Current assets
$96M
Total assets
$160M
Current liabilities
$29M
Total liabilities
$57M
Working capital
$68M
Retained earnings
−$968M
EBIT
−$76M
Total sales
$8M
Book equity
$103M
Accession 0001104659-26-020540. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.